Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

NCT02437604 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Treatment A: Fp MDPI
DRUG: Treatment B: FS MDPI
DRUG: Treatment C Flovent
DRUG: Treatment D: Advair

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.